Poodles!
Bluelighter
- Joined
- Dec 16, 2009
- Messages
- 145
A little more on topic... useful info on Silymarin and enzyme inhibition in general
This is a good thread. I've posted some useful stuff in this thread about enzyme inhibition and opioids (near the bottom).
• Opiate/Opioid Potentiators [INDERALL?]
Also recommended:
•Project - Codeine-6-Glucuronide (C6G)
• Messing with drug metabolism beyond the CYPs
• Sweet UGT enzyme chart (inhibitors/inducers)
• Awesome CYP-450 Chart!
• potentiation of drugs from milk thistle?
• Potentiate benzos with milk thistle?
• Milk Thistle Liver Detox = Lowered Opiate Tolerance?
Various useful stuff I've picked out:
Another good review article on Silymarin, although much of it isn't particularly relevant to the thread... It's just interesting :
This is a good thread. I've posted some useful stuff in this thread about enzyme inhibition and opioids (near the bottom).
• Opiate/Opioid Potentiators [INDERALL?]
Also recommended:
•Project - Codeine-6-Glucuronide (C6G)
• Messing with drug metabolism beyond the CYPs
• Sweet UGT enzyme chart (inhibitors/inducers)
• Awesome CYP-450 Chart!
• potentiation of drugs from milk thistle?
• Potentiate benzos with milk thistle?
• Milk Thistle Liver Detox = Lowered Opiate Tolerance?
Various useful stuff I've picked out:
Indeed, in recent experiments using milk thistle and human liver cells, the researchers found that
relatively small concentrations of milk thistle did significantly slow down the activity of the liver enzyme
CYP3A4 by 50% to 100%.
source: http://www.hcvadvocate.org/news/News...s/mthistle.pdf
The flavonolignans silybin A and silybin B from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations
source: http://jpet.aspetjournals.org/content/332/3/1081.full
Interactions between Natural Health Products and Antiretroviral Drugs: Pharmacokinetic and Pharmacodynamic Effects
There is a lot of good stuff in this review (pub.2006), the whole text is available so I recommend having a skim through at least, and also checking out relevant references... but here's some particularly thread-relevant bits:
…"Silybins, the active components of milk thistle, were found to inhibit CYP3A4 in vitro [25] and, thus, could increase ARV drug concentrations."…
…"Silymarin, a component of milk thistle, inhibits P-gp activity and enhances doxorubicin toxicity in vitro [36]. Other NHPs that inhibit P-gp in vitro include garlic, green tea, turmeric, ginseng, rosemary, flavonoids from many plants [37], African potato, and S. frutescens [28]. However, data are lacking on the clinical significance of these effects on P-gp."…
…"Two uncontrolled clinical studies [41, 42] revealed trends toward reduction in concentrations of indinavir after coadministration of milk thistle. A 3-period, randomized, controlled trial revealed a similar trend; however, there was an even greater reduction in area under the curve (AUC; 21.5%), trough concentrations (Cmin; 53.1%), and peak concentrations (Cmax; 9.4%) in subjects in the control group, which persisted after a washout period [43]. Compared with the control group, the milk thistle group demonstrated a significant but small increase in Cmin and trends toward increases in AUC and Cmax (table 1). Other clinical studies involving milk thistle and CYP3A4 [44] or P-gp [45] probe drugs revealed no pharmacokinetic interactions, indicating that clinically important interactions between milk thistle and PIs or NNRTIs are unlikely."…
http://cid.oxfordjournals.org/content/43/8/1052.full
Clinical Evidence of Herbal Drugs As Perpetrators of Pharmacokinetic Drug Interactions.
..."The clinical evidence was found to be most robust and informative for Gingko biloba (GB; 21 studies) and milk thistle/silymarin (MT; 13), and appears still limited for ginseng (9), goldenseal/berberine (GS; 8), garlic (8), and Echinacea (7). Collectively, the available evidence indicates that, at commonly recommended doses, none of these herbs act as potent or moderate inhibitors or inducers of cytochrome P450 (CYP) enzymes or P-glycoprotein (ABCB1). Weak effects in terms of either induction or inhibition were found for GB (presystemic/hepatic CYP3A4 induction/inhibition, CYP2C19 induction at high doses), milk thistle/silymarin ([weak]CYP2C9 inhibition), GS/berberine (CYP3A4 and CYP2D6 inhibition), Echinacea (presystemic/hepatic CYP3A4 inhibition/induction, CYP1A2 and CYP2C9 inhibition at high doses). Information was found not always complete for the major drug metabolizing CYP enzymes in the less well-studied herbs and is largely limited to P-glycoprotein (ABCB1) when effects on drug transporters have been investigated."
http://www.ncbi.nlm.nih.gov/pubmed/22855269
A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
..."The standardized extract known as silymarin contains three flavonoids of the flavonol subclass. Silybin predominates, followed by silydianin and silychristin. Although silybin is the most potent of the flavonoids in milk thistle, similar to other flavonoids it is not well-absorbed. Silybinphosphatidylcholine complexed as a phytosome provides significant liver protection and enhanced bioavailability over conventional silymarin."...
http://www.altmedrev.com/publications/10/3/193.pdf [Full text .PDF]
Bioavailability and Activity of Phytosome Complexes from Botanical Polyphenols: The Silymarin, Curcumin, Green Tea, and Grape Seed Extracts
..."Silybin is a proven liver protectant; in animal experiments it blocked the oxidative toxicities of acetaminophen, alcohol, carbon tetrachloride, and the mushroom toxins phalloidin and alpha-amanitin"...
..."Although in animal experiments and some human studies, milk thistle constituents have conserved liver glutathione, inhibited liver fibrogenesis, and supported liver regeneration,4,8 clinical trials have been inconsistent. In trials of viral hepatitis,18 alcoholic liver damage,19 or other liver diseases, silymarin and silybin improved enzyme damage indicators and (at times) improved antioxidant status,4,18,19 but did not consistently improve symptoms."...
…"The utilization of non-phytosome silybin intravenously in mushroom-toxic patients (at 20-50 mg/kg/day) or of high-dose silymarin at 600 mg/day in diabetic patients has resulted in meaningful symptom improvement,19 presumably because the preparations were given either intravenously or at a high oral dose. Overall, the efficacy patterns are consistent with poor intestinal absorption of these important flavonolignans, making the phytosome form a more appropriate oral delivery vehicle for this class of polyphenols."...
NSFW:
NSFW as it's a pretty large image/graph
http://www.altmedrev.com/publications/14/3/226.pdf [Full text .PDF]
Occurrence of aflatoxins in milk thistle herbal supplements.
..."A total of 83 MT samples from the US market were analysed. AFs were detected in 19% of the samples with levels ranging from 0.04 to 2.0 µg kg(-1). Additionally, an aflatoxigenic A. flavus strain from ATTC and an A. parasiticus strain isolated from MT herb powder were found to produce high amounts of aflatoxins (11,200 and 49,100 µg kg(-1), respectively) when cultured in MT seed powder. This is the first study reporting on aflatoxin contamination of MT botanical supplements and identifying methodology for AF analysis of these commodities."
http://www.ncbi.nlm.nih.gov/pubmed/22439650
Another good review article on Silymarin, although much of it isn't particularly relevant to the thread... It's just interesting :
SILYBIN AND SILYMARIN – NEW EFFECTS AND APPLICATIONS
http://mefanet.upol.cz/BP/2005/1/29.pdf [Full Text .PDF]
Last edited: